{
  "id": "f02d7808b1e50799",
  "title": "STAT+: Pharmalittle: We\u2019re reading about FDA voucher worries, weight loss drugs and jet fuel, and more",
  "description": "Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines over possible legal risks",
  "content": "Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines over possible legal risks",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/16/trump-fda-voucher-obesity-novo-lilly-covid/?utm_campaign=rss",
  "published_at": "2026-01-16T14:30:15+00:00",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about FDA voucher worries, weight loss drugs and jet fuel, and more",
    "description": "Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines over possible legal risks",
    "url": "https://www.statnews.com/pharmalot/2026/01/16/trump-fda-voucher-obesity-novo-lilly-covid/?utm_campaign=rss",
    "published": "2026-01-16T14:30:15+00:00",
    "source": "STAT"
  }
}